According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products ...

Also: Best digital notebooks of 2025 Drawing tablets come in two main forms: pen displays, which feature built-in screens for immersive experiences, and pen tablets. These require an external ...

Since the Adonit Mark is less precise than other premium pen competitors, this stylus is best for casual note-taking, as opposed to more detailed sketching. One thing’s for certain: at this ...

There are currently shortages of the Fiasp FlexTouch insulin pen which could affect people living with diabetes who take Fiasp insulin. Here’s what you need to know.

Tala Motazedi, a queer screenwriter from Iran, has had a very busy year indeed as the PEN Writer-in-Residence at George Brown College. Her work at the College began in September. … ...